Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®
Jonathan I. Silverberg, Marjolein de Bruin-Weller, Brian M. Calimlim, Xiaofei Hu, Sarah A. Ofori, Andrew M. Platt, Henrique D. Teixeira, Kilian Eyerich, Jacob P. Thyssen
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
1Zitat
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®“. Zusammen bilden sie einen einzigartigen Fingerprint.